E-DRUG: Rosiglitazone suspended in India
----------------------------------------
After the ban in Europe, restrictions in USA, India suspend the manufacture & import of Rosiglitazone (antidiabetic) from Oct. 7. It was reported that the drug produce commendable adverse cardiac events and bad lipid profiles.
Please check the Drug Controller General of India messages of ipabengal@gmail.com
Dixon Thomas
dixondisc@yahoo.com